IPO Year: 2022
Exchange: NASDAQ
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 3/4/2025 | $10.00 | Buy | D. Boral Capital |
D. Boral Capital initiated coverage of Tevogen Bio with a rating of Buy and set a new price target of $10.00
4 - Tevogen Bio Holdings Inc. (0001860871) (Issuer)
4 - Tevogen Bio Holdings Inc. (0001860871) (Issuer)
4 - Tevogen Bio Holdings Inc. (0001860871) (Issuer)
4 - Tevogen Bio Holdings Inc. (0001860871) (Issuer)
4 - Tevogen Bio Holdings Inc. (0001860871) (Issuer)
4 - Tevogen Bio Holdings Inc. (0001860871) (Issuer)
4 - Tevogen Bio Holdings Inc. (0001860871) (Issuer)
4 - Tevogen Bio Holdings Inc. (0001860871) (Issuer)
4 - Tevogen Bio Holdings Inc. (0001860871) (Issuer)
4 - Tevogen Bio Holdings Inc. (0001860871) (Issuer)
424B3 - Tevogen Bio Holdings Inc. (0001860871) (Filer)
EFFECT - Tevogen Bio Holdings Inc. (0001860871) (Filer)
424B3 - Tevogen Bio Holdings Inc. (0001860871) (Filer)
8-K - Tevogen Bio Holdings Inc. (0001860871) (Filer)
S-3 - Tevogen Bio Holdings Inc. (0001860871) (Filer)
424B3 - Tevogen Bio Holdings Inc. (0001860871) (Filer)
8-K - Tevogen Bio Holdings Inc. (0001860871) (Filer)
424B3 - Tevogen Bio Holdings Inc. (0001860871) (Filer)
10-Q - Tevogen Bio Holdings Inc. (0001860871) (Filer)
424B3 - Tevogen Bio Holdings Inc. (0001860871) (Filer)